Dipna Pharmachem Current Share Price | Dipna Pharmachem Stock Screener
DPL
Pharmaceuticals
Dipna Pharmachem Current Stock Price Today
Track the current Dipna Pharmachem share price and stock price live with TickJournal's free stock screener.
Browse DPL financial statements to support your investment research.
Use the Dipna Pharmachem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Dipna Pharmachem Market Cap
₹13.12 Cr.
DPL P/E Ratio (TTM)
5.24
Dipna Pharmachem P/B Ratio
0.22
EPS (TTM)
₹1.00
Dividend Yield
-
Debt to Equity
0.48
DPL 52 Week High
-
Dipna Pharmachem 52 Week Low
-
Operating Margin
4.00%
Profit Margin
2.33%
DPL Revenue (TTM)
₹129.00
EBITDA
₹5.00
Net Income
₹3.00
Total Assets
₹206.00
Total Equity
₹62.00
Dipna Pharmachem Current Share Price Chart
Track the current Dipna Pharmachem share price and stock price with an interactive chart. Analyse DPL price trends, trading volume, historical performance, and volatility across different timeframes — the complete Dipna Pharmachem stock quote in one place.
Dipna Pharmachem Company Profile - Fundamental Screener
Screen Dipna Pharmachem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for DPL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0MC401013
Dipna Pharmachem Balance Sheet Screener
Screen DPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total Assets | 206 | 132 | 133 | 78 | 36 | 25 | 18 | 14 | 11 |
| Current Assets | 154 | 132 | 133 | 78 | 36 | 25 | 18 | 14 | 11 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | |||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 10 | 9 | 13 | 11 | 6 | 4 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||||
| Total Equity | 62 | 39 | 38 | 24 | 2 | 1 | 1 | 1 | 1 |
| Share Capital | 26 | 24 | 24 | 12 | 0 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 36 | 14 | 14 | 12 | 2 | 1 | 1 | 1 | 0 |
Dipna Pharmachem Income Statement Screener - Profit & Revenue Analysis
Screen Dipna Pharmachem income statement and profit fundamentals.
Analyze DPL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Dipna Pharmachem share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 129 | 125 | 164 | 100 | 73 | 31 | 31 | 20 | 17 |
| Expenses | 124 | 122 | 161 | 98 | 71 | 31 | 31 | 20 | 17 |
| EBITDA | 5 | 3 | 3 | 2 | 2 | 0 | 0 | 0 | 0 |
| Operating Profit % | 4.00% | 3.00% | 2.00% | 2.00% | 3.00% | 1.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 4 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 0 |
| Tax | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| EPS | 1.00 | 0.41 | 0.45 | 0.76 | 333.39 | 6.91 | 16.86 | 9.15 | 17.27 |
Dipna Pharmachem Cash Flow Screener - Liquidity Fundamentals
Screen DPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | -9 | -5 | -21 | 3 | -2 | -3 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | -4 | 14 | 27 | -3 | 3 | 3 |
| Net Cash Flow | -13 | 8 | 6 | 0 | 0 | 0 |
Dipna Pharmachem Shareholding Pattern Screener
See Dipna Pharmachem shareholding pattern with promoter, FII, and DII holdings.
Check Dipna Pharmachem promoter holding and ownership changes for DPL on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Sept | 2025-Nov | 2024-Mar | 2024-Sept | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 9.13% | 9.13% | 9.98% | 9.98% | 9.13% | 9.98% | 9.98% | 66.56% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 79.16% | 81.17% | 71.21% | 73.74% | 79.11% | 63.07% | 81.82% | 31.36% |
| Other Holding | 11.71% | 9.71% | 18.81% | 16.28% | 11.76% | 26.95% | 8.20% | 2.08% |
| Shareholder Count | 1,717 | 1,788 | 1,997 | 1,742 | 1,741 | 1,807 | 2,652 | 992 |
Dipna Pharmachem Share Dividend Screener - Share Yield Analysis
Check Dipna Pharmachem dividend history with payout and yield data.
View Dipna Pharmachem dividend details including ex-dates and amounts for DPL stock.
Dipna Pharmachem Stock Index Membership
See which indices include Dipna Pharmachem stock.
Check DPL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Dipna Pharmachem Market Events Screener - Corporate Actions
Get Dipna Pharmachem corporate actions including splits, bonuses, and buybacks.
Check Dipna Pharmachem stock events that may affect DPL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-02 | 2026-07-02 | Quarterly Result Announcement | NA | -9.72% |
| 2025-11-26 | 2025-11-26 | Quarterly Result Announcement | NA | -10.55% |
| 2025-08-30 | 2025-08-30 | Annual General Meeting | NA | -5.94% |
| 2025-07-07 | 2025-07-07 | Quarterly Result Announcement | NA | 3.65% |
| 2025-04-04 | 2025-04-04 | Extraordinary General Meeting | NA | 10.31% |
| 2024-12-11 | 2024-12-11 | Quarterly Result Announcement | NA | 0.00% |
| 2024-08-27 | 2024-08-27 | Annual General Meeting | NA | 15.01% |
| 2024-02-12 | 2024-02-12 | Rights | 13:12 | 27.52% |
| 2024-01-03 | 2024-01-03 | Extraordinary General Meeting | NA | -10.98% |
Dipna Pharmachem Competitors Screener - Peer Comparison
Screen DPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 452,491 | 37.62 | 61,674 | 12.69% | 11,565 | 42.08 |
| Divis Laboratories | 254,186 | 84.45 | 11,067 | 13.95% | 2,568 | 73.44 |
| Torrent Pharmaceuticals | 188,662 | 86.68 | 13,886 | 20.34% | 2,138 | 51.61 |
| Zydus Life Science | 115,264 | 25.09 | 27,658 | 17.64% | 5,026 | 50.98 |
| Cipla | 111,806 | 33.60 | 29,045 | 2.24% | 3,870 | 37.48 |
| Laurus Labs | 105,105 | 92.58 | 6,868 | 22.01% | 890 | 66.90 |
| Aurobindo Pharma | 97,354 | 25.71 | 34,145 | 5.56% | 3,503 | 60.75 |
| Lupin | 96,234 | 17.34 | 29,039 | 26.75% | 5,356 | 25.42 |
| Dr Reddys Laboratories | 96,070 | 30.02 | 35,059 | 3.90% | 4,158 | 40.13 |
| Mankind Pharma | 95,361 | 46.39 | 14,636 | 14.85% | 1,938 | 36.72 |
Dipna Pharmachem Company Announcements - News Screener
Screen DPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-02 | Submission Of Integrated Financials | - |
| 2026-07-02 | Submission Of Statement Of Deviation And Variation | - |
| 2026-07-02 | Submission Of Financial Results | - |
| 2026-07-02 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 2Nd July 2026 | - |
| 2026-07-02 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2026-07-02 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2026-07-02 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-07-02 | Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-07-01 | Board Meeting Outcome for Outcome And Intimation For Rescheduling Of Board Meeting To 2Nd July 2026 | - |
| 2026-07-01 | Board Meeting Intimation for Outcome And Intimation For Rescheduling Of Board Meeting To 2Nd July 2026 | - |
| 2026-06-30 | Closure of Trading Window | - |
| 2026-06-27 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday 1St July 2026 | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-25 | Voting Results For Postal Ballot | - |
| 2026-05-25 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-04-24 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-22 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-04-22 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |